Allgemeine Neurologie, Universitätsklinik für Neurologie, Medizinische Universität Graz

Literatur:

1 Martin CL et al., Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 2006; 29(2):340–4

2 MacDonald PK et al., The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123( Pt 4):665–76

3 Sima AA et al., Diabetic neuropathies. Diabetologia 1997; 40(Suppl 3):B74–7

4 Moylan CK, Binder EF, Falls in older adults: risk assessment, management and prevention.Am J Med 2007; 120(6):493.e1–6

5 DCCT Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM 1993; 329:977–86

6 Ziegler D et al., Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006; 29(11):2365–70

7 Reichstein L et al., Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation. Diabetologia 2005; 48(5):824–8

8 Smith AG et al., Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006; 29(6):1294–9